[1]
Kanoun, R.Y. et al. 2023. Role of measurable residual disease quantified by 4 to 6 color flow cytometry before allogeneic hematopoietic stem cell transplantation for high-risk Philadelphia-negative acute lymphoblastic leukemia. Journal of Stem Cell Therapy and Transplantation. 7, 1 (Apr. 2023), 016–023. DOI:https://doi.org/10.29328/journal.jsctt.1001031.